Company Insider Tape

Lantern Pharma Inc insider transactions

Executive and director filing history, acquisition and disposal balance, executive concentration, cadence, and stored market context.

Symbol LTRN Latest filing 12 May 2026

Company Read

Net acquisition

LTRN has 4 stored insider filings. Acquisitions account for 50.0% of classified filings and disposals account for 50.0%. The largest stored filing is $100.0K from KEYSER, D JEFFREY.

Latest filing 12 May 2026most recent stored row
Largest filing $100.0Kreported transaction value
Total filings 4stored transaction rows
Acquisition value $200.0K2 acquisitions
Disposal value $02 disposals
Net value $200.0Kacquisitions minus disposals

Filing cadence

Last 12 active months
May 2026 4

Acquisitions 50.0% · Disposals 50.0%

May 2026 $200.0K

Executive concentration

By filing count
KEYSER, D JEFFREY Director · 2 filings
SCHALOP, LEE TROY Director · 2 filings

Market Context

LTRN weekly market snapshot

Week 31 Jul 2026
Latest close 2.63 USDstored weekly close
1-week move -4.4%latest weekly bar
13-week move -33.8%medium-term context
Relative Strength -27.7Sharemaestro indicator
Fair value gap -33.7%price vs fair value
Trend signal 1smoothed trend state

Transaction History

Latest insider filings for LTRN

Showing 1-4 of 4
Date 12 May 2026
Insider KEYSER, D JEFFREYDirector
Side Acquisition
Shares 48544
Price 2.06
Value 100001
Security Common stock, $0.001 par value
Date 12 May 2026
Insider SCHALOP, LEE TROYDirector
Side Acquisition
Shares 48544
Price 2.06
Value 100001
Security Common stock, $0.001 par value
Date 12 May 2026
Insider KEYSER, D JEFFREYDirector
Side Disposal
Shares 48544
Price 0.00
Value 0
Security Common stock purchase warrant (Right to Buy)
Date 12 May 2026
Insider SCHALOP, LEE TROYDirector
Side Disposal
Shares 48544
Price 0.00
Value 0
Security Common stock purchase warrant (Right to Buy)